Shares of CombiMatrix, Helicos Hit Hard in Tough May for Stock Market | GenomeWeb

This is a corrected version of an article that appeared briefly on the GenomeWeb site earlier Wednesday that contained incorrect historical stock data.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of CombiMatrix and Helicos BioSciences dropped sharply during the month of May, as the broader market sagged and both firms recently announced restructurings and reported declines in first-quarter revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.